Yoga May Aid Heart Failure Outcomes When Added to Optimal Medical Therapy
MONDAY, Oct. 2, 2023 (HealthDay News) — Yoga therapy may improve physical well-being and left ventricular function among heart failure patients on guideline-directed optimal medical therapy, according to a study presented at the American College of C…
Learn MoreYoga May Aid Heart Failure Outcomes When Added to Optimal Medical Therapy
MONDAY, Oct. 2, 2023 (HealthDay News) — Yoga therapy may improve physical well-being and left ventricular function among heart failure patients on guideline-directed optimal medical therapy, according to a study presented at the American College of C…
Learn MoreStrike a Pose: Yoga Helps Heart Failure Patients
TUESDAY, Sept. 26, 2023 (HealthDay News) — Heart failure can make everyday activities and exercise tough to carry out, but yoga might be a beneficial add-on to standard care.A new study from India finds this ancient practice improves quality of life …
Learn MoreNovel Model Aids Prediction of Survival in Heart Failure With Reduced Ejection Fraction
MONDAY, Sept. 25, 2023 (HealthDay News) — For individuals with heart failure with reduced ejection fraction (HFrEF), a new model facilitates prediction of lifelong overall and heart failure hospitalization-free survival and treatment benefit, accordi…
Learn MoreESC: Catheter Ablation Aids Symptomatic Atrial Fibrillation, End-Stage Heart Failure
WEDNESDAY, Aug. 30, 2023 (HealthDay News) — For patients with atrial fibrillation and end-stage heart failure, the combination of catheter ablation and guideline-directed medical therapy is associated with a lower likelihood of a composite of all-cau…
Learn MoreESC: Semaglutide Beneficial for HFpEF Patients With Obesity
TUESDAY, Aug. 29, 2023 (HealthDay News) — For patients with heart failure with preserved ejection fraction and obesity, semaglutide is associated with a larger reduction in symptoms and physical limitations, according to a study published online Aug….
Learn MoreESC: Treating Iron Deficiency May Not Aid Heart Failure Patients
TUESDAY, Aug. 29, 2023 (HealthDay News) — Ferric carboxymaltose does not improve a hierarchical composite outcome of death, heart failure hospitalizations, and exercise function in ambulatory patients with heart failure with reduced ejection fraction…
Learn MoreWegovy podría ser una nueva opción valiosa para los pacientes con insuficiencia cardiaca
VIERNES, 25 de agosto de 2023 (HealthDay News) — Wegovy (semaglutida), un medicamento para perder peso, y un medicamento relacionado dirigido a la diabetes, Ozempic, ya han alterado el tratamiento tanto de la obesidad como de la diabetes, y las venta…
Learn MoreWegovy May Be Valuable New Option for Heart Failure Patients
FRIDAY, Aug. 25, 2023 (HealthDay News) — Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing.Now, injected Wegovy could…
Learn MoreContar pasos no es solo para gente sana, también ayuda a los pacientes con insuficiencia cardiaca
MIÉRCOLES, 26 de julio de 2023 (HealthDay News) — Los dispositivos portátiles, como los relojes inteligentes, monitorizan de forma continua la actividad física, e instan a las personas a dar más pasos a diario para su salud. Ahora, un nuevo estudio s…
Learn More